NCT03788369

Brief Summary

This study evaluated the effectiveness and safety of Hybrid Coronary Revascularization in real-world practice.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
6

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Apr 2019

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 21, 2018

Completed
6 days until next milestone

First Posted

Study publicly available on registry

December 27, 2018

Completed
3 months until next milestone

Study Start

First participant enrolled

April 5, 2019

Completed
7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 13, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 13, 2026

Completed
Last Updated

April 15, 2026

Status Verified

April 1, 2026

Enrollment Period

7 years

First QC Date

December 21, 2018

Last Update Submit

April 13, 2026

Conditions

Coronary StenosisCoronary Artery Disease ProgressionCoronary Artery Bypass GraftingPercutaneous Coronary Revascularization

Keywords

Hybrid coronary revascularization

Outcome Measures

Primary Outcomes (1)

  • a composite event of death, myocardial infarction, TVR(Target Vessel Revascularization), or stroke.

    Patients who have experienced any one of the following events are considered to have experienced the composite outcome: death, myocardial infarction, TVR(Target Vessel Revascularization), or stroke.

    5 years

Secondary Outcomes (10)

  • All death

    5 years

  • Cardiac death

    5 years

  • Myocardial infarction

    5 years

  • a composite event of all death or myocardial infarction

    5 years

  • a composite event of cardiac death or myocardial infarction

    5 years

  • +5 more secondary outcomes

Study Arms (1)

Multivessel coronary artery disease

must include left anterior descending artery

Procedure: Hybrid Coronary Revascularization

Interventions

Hybrid Coronary RevascularizationPROCEDURE

Hybrid coronary revascularization (HCR) combines minimally invasive surgical coronary artery bypass grafting of the left anterior descending artery with percutaneous coronary intervention (PCI) of non-left anterior descending vessels.

Also known as: HCR
Multivessel coronary artery disease

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with hybrid coronary revascularization due to multivessel coronary artery disease(must include left anterior descending artery)

You may qualify if:

  • Age 20 and more
  • Hybrid coronary revascularization due to multivessel coronary artery disease(must include left anterior descending artery)
  • Written consent

You may not qualify if:

  • Previous CABG(coronary artery bypass graft)
  • Life expectancy ≤1 year

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Asan Medical Center

Seoul, South Korea

Location

MeSH Terms

Conditions

Coronary Stenosis

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Professor, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea

Study Record Dates

First Submitted

December 21, 2018

First Posted

December 27, 2018

Study Start

April 5, 2019

Primary Completion

April 13, 2026

Study Completion

April 13, 2026

Last Updated

April 15, 2026

Record last verified: 2026-04

Locations

KR(1)